전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article

References

  1. Reichenbach H. 2005. Myxococcales, pp. 1059-1144. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM (eds), Bergey's Manual of Systematic Bacteriology, 2nd Ed. Bergey's Manual Trust, East Lansing, MI, USA.
  2. Shimkets LJ, Dworkin M, Reichenbach H. 2006. The myxobacteria, pp. 31-115. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (eds), The Prokaryotes, Vol. 7. Springer, New York, NY, USA.
    CrossRef
  3. Weissman KJ, Muller R. 2010. Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat. Prod. Rep. 27: 1276-1295.
    Pubmed CrossRef
  4. Herrmann J, Fayad AA, Müller R. 2017. Natural products from myxobacteria: novel metabolites and bioactivities. Nat. Prod. Rep. 34: 135-160.
    Pubmed CrossRef
  5. Meiser P, Bode HB, Muller R. 2006. The unique DKxanthene secondary metabolite family from the myxobacterium Myxococcus xanthus is required for developmental sporulation. Proc. Natl. Acad. Sci. USA 103: 19128-19133.
    Pubmed PMC CrossRef
  6. Meiser P, Weissman KJ, Bode HB, Krug D, Dickschat JS, Sandmann A, et al. 2008. DKxanthene biosynthesis -understanding the basis for diversity-oriented synthesis in myxobacterial secondary metabolism. Chem. Biol. 15: 771-781.
    Pubmed CrossRef
  7. Burchard RP, Burchard AC, Parish JH. 1977. Pigmentation phenotype instability in Myxococcus xanthus. Can. J. Microbiol. 23: 1657-1662.
    Pubmed CrossRef
  8. Furusawa G, Dziewanowska K, Stone H, Settles M, Hartzell P. 2011. Global analysis of phase variation in Myxococcus xanthus. Mol. Microbiol. 81: 784-804.
    Pubmed PMC CrossRef
  9. Laue BE, Gill RE. 1995. Using a phase-locked mutant of Myxococcus xanthus to study the role of phase variation in development. J. Bacteriol. 177: 4089-4096.
    Pubmed PMC CrossRef
  10. Wenzel SC, Müller R. 2009. The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat. Prod. Rep. 26: 1385-1407.
    Pubmed CrossRef
  11. Sasse F, Steinmetz H, Höfle G, Reichenbach H. 1993. Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physico-chemical and biological properties. J. Antibiot. (Tokyo) 46: 741-748.
    Pubmed CrossRef
  12. Sasse F, Bohlendorf B, Herrmann M, Kunze B, Forche E, Steinmetz H, et al. 1999. Melithiazols, new betamethoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties. J. Antibiot. (Tokyo) 52: 721-729.
    Pubmed CrossRef
  13. Trowitzsch-Kienast W, Forche E, Wray V, Reichenbach H, Jurkiewicz E, Hunsmann G, Höfle G. 1992. Antibiotika aus gleitenden bakterien, 45.phenalamide, neue HIV-1-inhibitoren aus Myxococcus stipitatus Mx s40. Liebigs Ann. Chem. 1992: 659-779.
    CrossRef
  14. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, Fischbach MA, et al. 2011. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters. Nucleic Acids Res. 39: W339-W346.
    Pubmed PMC CrossRef
  15. Weber T, Blin K, Duddela S, Krug D, Kim HU, Bruccoleri R, et al. 2015. antiSMASH 3.0 - a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 43: W237-W243.
    Pubmed PMC CrossRef
  16. Johnson M, Zaretskaya I, Raytselis Y, Mereshuk Y, McGinnis S, Madden TL. 2008. NCBI BLAST: a better web interface. Nucleic Acids Res. 36: W5-W9.
    Pubmed PMC CrossRef
  17. Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, et al. 2015. CDD: NCBI's conserved domain database. Nucleic Acids Res. 43: D222-D226.
    CrossRef
  18. Cho K, Zusman DR. 1999. Sporulation timing in Myxococcus xanthus is controlled by the espAB locus. Mol. Microbiol. 34: 714-725.
    Pubmed CrossRef
  19. Shi W, Köhler T, Zusman DR. 1994. Motility and chemotaxis in Myxococcus xanthus. Methods Mol. Genet. 3: 258-269.
  20. Shin H, Youn J, An D, Cho K. 2013. Production of antimicrobial substances by strains of myxobacteria Corallococcus and Myxococcus. Korean J. Microbiol. Biotechnol. 41: 44-51.
    CrossRef
  21. Zimbro MJ, Power DA, Miller SM, Wilson GE, Johnson JA (eds). 2009. Difco and BBL Manual: Manual of Microbiological Culture Media, 2nd Ed. Zimbro MJ, Power DA, Miller SM, Wilson GE, Johnson JA (eds). Becton Dickinson and Co., Sparks, MD, USA.
  22. Park S, Hyun H, Lee JS, Cho K. 2016. Identification of the phenalamide biosynthetic gene cluster in Myxococcus stipitatus DSM 14675. J. Microbiol. Biotechnol. 26: 1636-1642.
    Pubmed CrossRef
  23. Huntley S, Kneip S, Treuner-Lange A, Sogaard-Andersen L. 2013. Complete genome sequence of Myxococcus stipitatus strain DSM 14675, a fruiting myxobacterium. Genome Announc. 1: e0010013.
    Pubmed PMC CrossRef
  24. Hyun H, Park S, Cho K. 2016. Analysis of the melithiazol biosynthetic gene cluster in Myxococcus stipitatus DSM 14675. Microbiol. Biotechnol. Lett. 44: 391-399.
    CrossRef
  25. Bérdy J. 2012. Thoughts and facts about antibiotics: where we a re now and where we are heading. J. Antibiot. (Tokyo) 65: 385-395.
    Pubmed CrossRef
  26. Schäberle TF, Lohr F, Schmitz A, König GM. 2014. Antibiotics from myxobacteria. Nat. Prod. Rep. 31: 953-972.
    Pubmed CrossRef
  27. Keane R, Berleman J. 2016. The predatory life cycle of Myxococcus xanthus. Microbiology 162: 1-11.
    Pubmed CrossRef
  28. Dey A, Vassallo CN, Conklin AC, Pathak DT, Troselj V, Wall D. 2016. Sibling rivalry in Myxococcus xanthus is mediated by kin recognition and a polyploid prophage. J. Bacteriol. 198: 994-1004.
    Pubmed PMC CrossRef

Related articles in JMB

More Related Articles

Article

Research article

J. Microbiol. Biotechnol. 2018; 28(7): 1068-1077

Published online July 28, 2018 https://doi.org/10.4014/jmb.1802.02045

Copyright © The Korean Society for Microbiology and Biotechnology.

Genetic and functional analysis of the DKxanthene biosynthetic gene cluster from Myxococcusstipitatus DSM 14675

Hyesook Hyun 1, Sunjin Lee 1, Jong Suk Lee 2 and Kyungyun Cho 1*

1Department of Biotechnology, Hoseo University, Asan 31499, Republic of Korea, 2Biocenter,Gyeonggido Business & Science Accelerator (GBSA), Suwon 16229, Republic of Korea

Received: February 26, 2018; Accepted: May 29, 2018

Abstract

DKxanthenes area class of yellow secondary metabolites produced by myxobacterial genera Myxococcusand Stigmatella. We identified a putative 49.5 kb DKxanthene biosynthetic gene cluster from M. stipitatus DSM 14675 by genomic sequence and mutational analysis. The cluster was comprisedof 15 genes (MYSTI_06004-MYSTI_06018) encoding polyketide synthases, non-ribosomal peptide synthases, and proteins with unknown functions. Disruption of the genes by plasmid insertion resulted in defects in the production of yellow pigments. High-performance liquid chromatography and liquid chromatography-tandem mass spectrometryanalysis indicated that the yellow pigments produced by M. stipitatus DSM 14675 might be noble DKxanthene derivatives.M. stipitatus did not require DKxanthenes for the formation of heat-resistant viable spores,unlike M. xanthus. Furthermore, DKxanthenes showed growth inhibitory activity against the fungi Aspergillusniger, Candida albicans, and Rhizopusstolonifer.

Keywords: Myxobacteria, Myxococcus stipitatus, secondary metabolite, DKxanthene, biosynthetic gene

Introduction

Myxobacteria are gram-negative soil bacteria that are well known for the production of diverse bioactive secondary metabolites [1-4]. DKxanthenes are a class of yellow pigments produced by myxobacteria belonging to the genera Myxococcus and Stigmatella (Fig. 1) [5, 6]. Myxococcus xanthus displays phase variations between yellow- and tan-phase cells [7]. DKxanthenes are produced by yellow-phase cells but not by tan-phase cells [8]. DKxanthenes are required for developmental sporulation in M. xanthus. Mutant cells of M. xanthus defective in DKxanthene biosynthesis produce severely reduced amounts of heat-resistant viable spores [5]. It has been suggested that tan-phase cells are the progenitors of spores and yellow-phase cells provide factors that tan-phase cells need to produce viable spores [9]. Later, DKxanthene was suggested as one of the factors needed by tan-phase cells for the maturation of spores in M. xanthus [5].

Figure 1. Structure of DKxanthenes [5, 6].

The majority of secondary metabolites isolated from myxobacteria are biosynthesized by polyketide synthases (PKSs) and/or non-ribosomal peptide synthases (NRPSs)[10]. DKxanthenes are also biosynthesized by PKSs and NRPSs. The structure of DKxanthenes from M. xanthus was elucidated and their biosynthetic gene clusters were identified in M. xanthus DK1622 and Stigmatella aurantiaca DW4/3-1 [5, 6]. The organization of the two biosynthetic gene clusters identified in M. xanthus DK1622 and S. aurantiaca DW4/3-1 was similar but not identical. Both clusters have core PKS and NRPS genes for the production of the DKxanthene backbone structure. However, S. aurantiaca has additional PKS genes, dkxQR and dkxT. The organization of the associated genes was also different (Fig. 2) [6]. A total of 13 DKxanthene derivatives were identified from M. xanthus DK1622, whereas S. aurantiaca DW4/3-1 was reported to produce five derivatives among them [6].

Figure 2. Biosynthetic gene clusters of DKxanthene. DKxanthene biosynthetic gene clusters from Myxococcus stipitatus DSM 14675, Stigmatella aurantiaca DW4/3-1, and Myxococcus xanthus DK1622 are shown. Polyketide synthase (PKS); Non-ribosomal peptide synthetase (NRPS); PKS/NRPS hybrid. Arrows indicate the locations of the plasmid insertions, which disrupted the genes in the mutant strains.

M. stipitatus is another species of the genus Myxococcus. M. stipitatus forms multicellular fruiting bodies consisting of a spherical mass of slime and myxospores on a long stalk on the natural substrates [1]. M. stipitatus is known to produce melithiazol, rhizopodin, and phenalamide [11-13]. It also produces yellow pigments that appear to be DKxanthenes similar to those of M. xanthus. Herein, we report that the yellow pigments produced by M. stipitatus are new DKxanthene derivatives that have not been identified from M. xanthus and S. aurantiaca. We also report that DKxanthenes show growth inhibitory activity against fungi.

Materials and Methods

Strains

The microbial strains used in this study are listed in Table 1. M. stipitatus DSM 14675 was purchased from Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ). M. stipitatus KYC617, KYC618, KYC633, KYC634, KYC635, KYC636, KYC637, and KYC638 were constructed by inserting plasmids pHS221, pHS222, pHS243, pHS244, pHS245, pHS246, pHS247, and pHS248, respectively, into the chromosome of strain DSM 14675 in this study. Aspergillus niger ATCC 16404, Candida albicans ATCC 18804, Pseudomonas aeruginosa ATCC 10145, and Staphylococcus aureus ATCC 25923 were obtained from the Korean Collection for Type Culture (KCTC). Rhizopus stolonifer KCCM 32398 was obtained from the Korean Culture Center of Microorganisms (KCCM).

Table 1 . Microbial strains used in this study..

StrainsRelevant featuresSource or references
Myxococcus xanthus DK1622Wild type[28]
Myxococcus stipitatus DSM 14675Wild typeDSMZa
Myxococcus stipitatus KYC617DSM14675 MYSTI_06016::pHS221This study
Myxococcus stipitatus KYC618DSM14675 MYSTI_06014::pHS222This study
Myxococcus stipitatus KYC633DSM14675 MYSTI_06019::pHS243This study
Myxococcus stipitatus KYC634DSM14675 MYSTI_06018::pHS244This study
Myxococcus stipitatus KYC635DSM14675 MYSTI_06010::pHS245This study
Myxococcus stipitatus KYC636DSM14675 MYSTI_06005::pHS246This study
Myxococcus stipitatus KYC637DSM14675 MYSTI_06004::pHS247This study
Myxococcus stipitatus KYC638DSM14675 MYSTI_06002::pHS248This study
Pseudomonas aeruginosa ATCC 10145Gram negative bacteriumKCTCb
Staphylococcus aureus ATCC 25923Gram positive bacteriumKCTC
Aspergillus niger ATCC 16404Fungus (Ascomycota, mold)KCTC
Candida albicans ATCC 18804Fungus (Ascomycota, yeast)KCTC
Rhizopus stolonifer KCCM 32398Fungus (Zygomycota, mold)KCCMc

aDSMZ, Deutsche Sammlung von Mikroorganismen und Zellkukulturen GmbH..

bKCTC, Korean Collection for Type Cultures..

cKCCM, Korean Culture Center of Microorganisms..



Sequence Analysis

DKxanthene biosynthetic gene clusters were analyzed using the antiSMASH program [14, 15]. DNA and amino acids sequences were analyzed using BLAST [16] and CD-Search [17] programs.

Plasmid and Strain Construction

The plasmids used in this study are listed in the supplementary Table S1. Plasmids pHS221, pHS222, pHS243, pHS244, pHS245, pHS246, pHS247, and pHS248 were constructed by inserting an internal DNA fragment of MYSTI_06016, MYSTI_06014, MYSTI_06019, MYSTI_06018, MYSTI_06010, MYSTI_06005, MYSTI_06004, or MYSTI_06002 into the pCR2.1 plasmid (Invitrogen, USA), respectively. Sequences of the oligonucleotide primers used to amplify the internal DNA fragments of the genes by polymerase chain reaction (PCR) are shown in the Table S2.

Plasmid insertion mutants were constructed as described previously [18]. Plasmid DNA was introduced into M. stipitatus DSM 14675 by electroporation using Gene Pulser II (Bio-Rad, USA). Kanamycin-resistant transformants were selected. Because pCR2.1 cannot replicate in M. stipitatus, only cells carrying a plasmid inserted on the chromosome by homologous recombination grew in the presence of kanamycin. The insertion of the plasmids into the designated locations was confirmed by PCR using a set of oligonucleotides as primers: one binds to the pCR2.1 vector DNA and the other binds to the chromosomal DNA near the insertion site. The primers used to confirm the insertions are listed in Table S2.

Media and Culture Conditions

CYE medium [19] was used for the vegetative growth of M. stipitatus and M. xanthus. CYS medium [20] was used for DKxanthene production. CYD agar was used for fruiting body development of M. stipitatus. CYD agar contained 0.25% (w/v) casitone, 0.1% (w/v) yeast extract, 0.1% (w/v) MgSO4•7H2O, 0.05%(w/v) CaCl2, 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.6), 0.1% (w/v) trace element solution, and 2.5% (w/v) agar. The trace element solution contained 100 mg MnCl2•4H2O, 20 mg CoCl2, 10 mg CuSO4, 10 mg Na2MoO4•2H2O, 20 mg ZnCl2, 5 mg LiCl, 5 mg SnCl2•2H2O, 10 mg H3BO3, 20 mg KBr, 20 mg KI, and 8 g EDTA Na-Fe3+salt (trihydrate) per liter [2]. Trypticase soy agar (TSA) and tryptic soy broth [21] were used for the growth of fungi and other bacteria besides myxobacteria. All the strains were cultured at 30°C.

Preparation of Culture Extract

Myxobacterial cells cultured on CYS agar plates for 4 days at 30°C were collected with a scraper and extracted with methanol. The methanol was evaporated from the extract, and then a mixture of ethyl acetate and water in a 1:1 ratio (v/v) was added to the residue. The solution was centrifuged to separate the ethyl acetate and water layers. The ethyl acetate layer was recovered and dried. The dried residue was dissolved in 80% (v/v) methanol.

High-Performance Liquid Chromatography (HPLC) Analysis

HPLC was performed using an HPLC system (1260 VL Infinity Series; Agilent, USA) equipped with a Zorbax SB-C18 column (4.6 × 150 mm, 5 µm) (Agilent) and a diode array detector (1260 VL Infinity; Agilent). The mobile phase A was water and mobile phase B was acetonitrile, both of which contained 0.1% formic acid. The gradient elution at a flow rate of 0.5 ml/min was performed as follows: 0–5 min 5–40% B (linear gradient), 5–25 min 40–60% B (linear gradient), and 25–35 min 100% B (isocratic).

High-Resolution Liquid Chromatography Mass Spectrometry (LC-MS) Analysis

LC-MS was performed as previously described [22] with slight modifications. The mobile phase A was water and mobile phase B was acetonitrile, both of which contained 0.1% formic acid. The gradient elution at a flow rate of 0.4 ml/min was performed as follows: 0–1 min 5–30% B (linear gradient), 1–9 min 30–50% B (linear gradient), 9–10 min 50–100% B (linear gradient), and 10–12 min 100% B (isocratic).

Antimicrobial Assay

Paper discs of 6 mm diameter (Advantec MFS, Japan) containing 10 µl of sample solution (10 mg/ml) were dried and placed on TSA plates inoculated with test microorganisms. The plates were then incubated for 2 days.

Induction of Fruiting Body Development and Analysis of Viable Spore Formation

For inducing fruiting body development, 1 × 106 cells, which were grown on CYE broth until the absorbance of the culture broth was 1.0 at 600 nm, were placed on CYD plates as a 20 µl spot and incubated at 30°C for 5 days. Cells in the spot were harvested with a scrapper and suspended in distilled water. Heat-resistant spores were counted on CYE plates after inactivating vegetative cells by incubating the harvested cells to 50°C for 2 h before sonication. Fruiting bodies were observed using a stereomicroscope (SMZ1000; Nikon, Japan), and individual cells and spores were observed using a phase-contrast microscope (Eclipse E600; Nikon).

Results

Identification of a Putative DKxanthene Biosynthetic Gene Cluster of M. stipitatus DSM 14675

Most strains of M. stipitatus produce yellow pigments that are predicted to be DKxanthenes. Because the DNA sequences of the DKxanthene biosynthetic gene clusters from M. xanthus DK1622 and S. aurantiaca DW4/3-1 were available, we analyzed the genome sequence of M. stipitatus DSM 14675 for the presence of a similar biosynthetic gene cluster. When the genome sequence of M. stipitatus DSM 14675 (GenBank Accession No. CP004025) [23] was analyzed with the antibiotics & Secondary Metabolite Analysis SHell (antiSMASH) program [14, 15], genes in a genomic region of 7,741,562-7,791,088 bp (approximately 49.5 kb) were predicted to be a putative DKxanthene biosynthetic gene cluster. This region contained 15 genes (MYSTI_06004-MYSTI_06018). The organization of the PKS and NRPS modules encoded by the genes in the region was very similar to that of the DKxanthene biosynthetic gene cluster from S. aurantiaca DW4/3-1 (Fig. 2, Table 2).

Table 2 . Comparison of the DKxanthene biosynthetic genes from M. stipitatus DSM 14675 and S. aurantiaca DW4/3-1..

M. stipitatus DSM 14675S. aurantiaca DW4/3-1


ORF No.Product size (aa)Predicted functionPKS/NRPS motifIdentity/Similarity (%)GeneORF No.Product size (aa)
06019183hypothetical protein----
06018498NRPSA(N/A)77/87dkxA4842507
06017380acyl-CoA dehydrogenase85/91dkxB4841379
06016711PKSKS-ACP64/73dkxE4840739
060151,418PKSKS-KR-ACP59/70dkxF48391,461
060142,958NRPS/PKSC-A(thr)-PCP-KS-AT(mal)-DH-KR-ACP74/84dkxG48382,971
060131,834PKSKS-AT(mal)-DH-KR-ACP70/81dkxH48371,855
060121,833PKSKS-AT(mal)-DH-KR-ACP68/79dkxI48361,837
060111,436NRPSC-A(asn)-PCP-TE69/81dkxJ48351,433
06010366patatin-like phospholipase family protein68/81dkxK4834365
06009381arsenical pump-driving ATPase49/62dkxL4833388
06008165hypothetical protein45/62dkxP4832159
06007931PKSoMT-KR-ACP67/78dkxQR4831941
06006674radical SAM domain-containing protein83/89dkxS4830673
060051,835PKSKS-AT(mal)-DH-KR-ACP72/81dkxN48291,866
06004947PKSKS-AT(N/A)70/80dkxT4828949
0600387hypothetical protein75/87-482787
06002172alpha-L-arabinofuranosidase----

A, adenylation; aa, amino acid; ACP, acyl carrier protein; asn, asparagine; AT, acyltransferase; C, condensation; DH, dehydrase; KR, ketoreductase; KS, ketosynthase; mal, malonate; mmal, methyl malonate; N/A, not available; NRPS, non-ribosomal peptide synthetase; oMT, O-methyl transferase; ORF, open reading frame; PCP, peptidyl carrier protein; PKS, polyketide synthase; SAM, S-adenosylmethionine-dependent methyltransferase; TE, thioesterase..

Identity/Similarity: Identity and similarity to the corresponding proteins of S. aurantiaca DW4/3-1..



Inactivation of the DKxanthene Biosynthetic Genes

To confirm whether the MYSTI_06004-MYSTI_06018 region encodes enzymes for DKxanthene production, we inactivated the genes in the region by plasmid insertion mutagenesis and tested whether the resulting mutants produce yellow pigments assumed to be DKxanthenes. We first created two mutants, KYC617 and KYC618. KYC617 was a mutant in which the MYSTI_06016 gene was disrupted by the insertion of plasmid pHS221. KYC618 was a mutant in which the MYSTI_06014 gene was disrupted by the insertion of plasmid pHS222.

The resulting two mutants were defective in the production of yellow pigments and formed tan colonies under the condition where the wild-type strain DSM 14675 produced yellow pigments and formed yellow colonies. When the culture extracts were analyzed by HPLC, approximately 11 peaks, which showed a maximum absorption at 410 nm, disappeared in the extracts of mutant strains KYC617 and KYC618 compared with the extract of the wild-type strain DSM 14675 (Fig. 3).

Figure 3. High-performance liquid chromatography chromatograms of the culture extracts of M. stipitatus strains DSM 14675, KYC617, and KYC618.

We also created KYC633, KYC634, KYC635, KYC636, KYC637, and KYC638 by inserting plasmids pHS243, pHS244, pHS245, pHS246, pHS247, and pHS248 into the MYSTI_06019, MYSTI_06018, MYSTI_06010, MYSTI_06005, MYSTI_06004, and MYSTI_06002 genes, respectively. All the mutants that had plasmid insertions in the MYSTI_06004-MYSTI_06018 region were defective in the production of yellow pigments (Fig. S1). However, mutants KYC633 and KYC638, which had plasmid insertions in MYSTI_06019 and MYSTI_06002, respectively, produced yellow pigments similar to the wild-type strain (Fig. S1). MYSTI_06002 and MYSTI_06019, which adjoined the MYSTI_06004-MYSTI_06018 region, were not conserved in the DKxanthene biosynthetic gene clusters from M. xanthus DK1622 and S. aurantiaca DW4/3-1. Meanwhile, MYSTI_06003 was a relatively small open reading frame with a size of 264 bp, which might encode a hypothetical protein with a size of 87 aa. Therefore, it was concluded that the MYSTI_06004-06018 region encoded enzymes for the production of yellow pigments assumed to be DKxanthenes in M. stipitatus DSM 14675.

Comparison of DKxanthenes from M. stipitatus DSM 14675 and M. xanthus DK1622

M. xanthus DK1622 has been reported to produce 13 derivatives of DKxanthene, including five derivatives produced by S. aurantiaca DW4/3-1 [5]. Therefore, we tested whether the yellow pigments produced by the wild-type strain of M. stipitatus but not by the insertion mutants were the same DKxanthenes produced by M. xanthus DK1622. Culture extracts of M. stipitatus DSM 14675 and M. xanthus DK1622 were prepared and analyzed using an HPLC equipped with a photodiode array detector. DKxanthenes from M. xanthus DK1622 were analyzed as peaks with retention times of 11–17 min. Meanwhile, yellow pigments from M. stipitatus DSM 14675 were analyzed as peaks with retention times of 13–17 min (Fig.S2). The absorption spectra of the 13–17 min peaks from M. stipitatus DSM 14675 were very similar to those of DKxanthenes from M. xanthus DK1622 (Fig.S2 inserts). Since derivatives of the same backbone structure generally have similar absorption spectra, this suggested that the yellow pigments from M. stipitatus DSM 14675 might be the derivatives of DKxanthenes.

To confirm this, the DKxanthene fraction of M. xanthus between 11 and 19 min and the yellow pigment fraction of M. stipitatus between 13 and 20 min were analyzed with LC-MS/MS. Four derivatives of DKxanthene reported previously (DKxanthene-534, -556, -560, and -574) were detected in the DKxanthene fraction of M. xanthus (Fig.4, Table 3). Four new derivatives that have not been reported previously (DKxanthene-516, -542, -574 isomer, and -588 isomer) were also detected in the DKxanthene fraction of M. xanthus. Under the same condition, the retention time and mass of DKxanthene derivatives in the yellow pigment fraction of M. stipitatus were totally different from those produced by M. xanthus (DKxanthene-528, -528 isomer, -546, -546 isomer, -562, -562 isomer, -572, and -588) (Fig.4, Table 3).

Table 3 . Comparison of the DKxanthenes produced by M. stipitatus DSM 14675 and M. xanthus DK1622..

RT(min)m/z ([M+H]+)Formula ([M+H]+)∆ppmDKxantheneKnown or novel
M. stipitatus DSM146756.16563.2880C31H39O6N41.935DKxanthene-562New
6.44547.2928C31H39O5N41.361DKxanthene-546New
6.53563.2875C31H39O6N40.888DKxanthene-562 isomerNew
6.88547.2923C31H39O5N40.539DKxanthene-546 isomerNew
7.12589.3031C33H41O6N40.883DKxanthene-588New
7.34529.2820C31H37O4N41.170DKxanthene-528New
7.44573.3083C33H41O5N41.142DKxanthene-572New
7.71529.2822C31H37O4N41.303DKxanthene-528 isomerNew
M. xanthus DK16224.46535.2556C29H35O6N40.524DKxanthene-534Known
4.94517.2455C29H33O5N40.744DKxanthene-516New
5.33561.2710C31H37O6N4-0.516DKxanthene-560Known
5.82575.2868C32H39O6N4-0.243DKxanthene-574Known
5.94543.2602C31H35O5N4-0.966DKxanthene-542New
6.32575.2875C32H39O6N41.269DKxanthene-574 isomerNew
6.53557.2758C32H37O5N4-1.050DKxanthene-556Known
6.81589.3028C33H41O6N40.136DKxanthene-588 isomerNew

The structural formula was estimated from the measured high-resolution mass spectrometry results using Xcalibur ver. 2.2 software (Thermo Scientific, USA). The molecular formula was selected within ±3 ppm mass accuracy..



Figure 4. High-resolution LC-MS analysis of the DKxanthenes produced by M. stipitatus DSM 14675 and M. xanthus DK1622. UV chromatograms of the DKxanthene fractions from M. stipitatus DSM 14675 (A) and M. xanthus DK1622 (B) at 410 nm. High-resolution mass spectra of the eight main peaks from M. stipitatus DSM 14675 (C) and M. xanthus DK1622 (D).

Effect of DKxanthenes on Fruiting Body Development and Spore Formation

Because DKxanthenes have been reported to be essential for fruiting body development and spore formation in M. xanthus [5], we tested whether the DKxanthenes were also essential for development in M. stipitatus. The wild-type cells of M. stipitatus DSM 1467 and mutant cells of KYC617 and KYC618, which were defective in DKxanthene production, were placed on CYD plates and incubated for fruiting body development. However, no difference between the wild-type strain and the mutant strains were observed in fruiting body development and spore formation except for the color of the fruiting bodies after 5 days. The fruiting bodies of the mutants were white or tan, whereas those of the wild-type strain were yellow (Fig. 5). No delay in fruiting body development was observed with the mutant strains compared with the wild-type strain. The mutant cells produced the same amounts of heat-resistant viable spores compared with that of the wild-type strain. A mutant strain of M. xanthus defective in DKxanthene production failed to produce heat-resistant viable spores under identical conditions (data not shown). Therefore, it was concluded that M. stipitatus DSM 14675 did not require DKxanthenes for fruiting body development and spore formation, unlike M. xanthus.

Figure 5. Effects of the inactivation of DKxanthene production on the formation of fruiting bodies. Approximately 1 × 106 cells of M. stipitatus DSM 14675 (A), KYC617 (B), and KYC618 (C) grown in CYE broth were placed on CYD plates as 20 μl spots and incubated at 30°C for 5 days. Cells aggregated and formed fruiting bodies consisting of a mass of slime and myxospores on the agar media. All three strains developed normal fruiting bodies. DSM 14675 formed yellow fruiting bodies, but KYC617 and KYC618 formed white fruiting bodies because they were defective in DKxanthene production. Bar, 0.2 mm.

Antimicrobial Activity of DKxanthenes

When we previously studied mutants that were defective in the production of melithiazols [24], we found that M. stipitatus DSM 14675 was producing other antifungal substances besides melithiazols. An HPLC analysis and antifungal activity assay indicated that those substances were DKxanthenes. When a paper disc containing 100 µg of the DKxanthene fraction of M. stipitatus DSM 14675 between 13–20 min was placed in the center of plates inoculated with P. aeruginosa or S. aureus, no growth inhibition of bacteria was observed. However, a paper disc containing the same amount of the DKxanthene fraction inhibited the growth of fungi A. niger, C. albicans, and R. stolonifer (Fig.6). The same fractions of culture extracts from mutants defective in DKxanthene (KYC617 and KYC618) did not show any growth inhibitory activity against these fungi under the same conditions. Because the DKxanthene fraction from M. stipitatus DSM 14675 showed antifungal activity, we tested the antifungal activity with the DKxanthene fraction from M. xanthus DK1622. The DKxanthene fraction from M. xanthus DK1622 also showed antifungal activity, although the activity against A. niger and C. albicans was lower than that of the fraction from M. stipitatus DSM 14675 (Fig. 6).

Figure 6. Antifungal activity of DKxanthenes from M. stipitatus DSM 14675 and M. xanthus DK1622. Paper discs containing 100 μg of DKxanthene fractions from M. stipitatus DSM 14675 or M. xanthus DK1622 were placed on TSA plates that had been spread with Aspergillus niger ATCC 16404, Candida albicans ATCC 18804, or Rhizopus stolonifer KCCM 32398. The plates were then incubated at 30°C for 2 days.

Discussion

Organization of DKxanthene Biosynthetic Gene Clusters and Their Products

DKxanthene biosynthetic gene clusters have been found in the genomes of strains belonging to genus Myxococcus and Stigmatella. DKxanthene biosynthetic gene clusters could be classified into two groups based on the organization of genes: MX type and SA type. The MX-type clusters are represented by the cluster identified in the genome of M. xanthus DK1622 (Fig. 2). SA-type clusters are represented by the cluster identified in the genome of S. aurantiaca DW4/3-1 (Fig. 2) [6]. Genomic sequence analysis indicated that M. xanthus, M. virescens, M. hansupus, and M. macrosporus have MX-type clusters, whereas M. stipitatus and M. fulvus have SA-type clusters. DKxanthene biosynthetic gene clusters are not found in the genomes of Corallococcus, a closely related genus to Myxococcus.

It has been reported that the core structure of DKxanthene is biosynthesized by PKSs and NRPSs in the order of DkxA, DkxB, DkxE, DkxF, DkxG, DkxN, DkxH, DkxI, and DkxJ [6]. Both MX- and SA-type clusters have genes for these PKSs and NRPSs in common. However, the SA-type clusters have additional genes, dkxP, dkxQR, dkxS, and dkxT, which were not found in the MX-type clusters (Fig.2), whereas they lack dkxC and dkxD, which were present in the MX-type clusters (Fig. 2). The dkxP gene was predicted to encode a hypothetical protein, the dkxQR gene a PKS with oMT-KR-ACP domains, the dkxS gene a radical SAM domain-containing protein, and the dkxD gene a PKS with KS-AT domains (Table 2). Meanwhile, the dkxC gene was predicted to encode a type 1 phosphodiesterase and the dkxD gene a FAD-dependent monooxyenase [6]. Therefore, it was expected that the MX- and SA-type clusters might produce different DKxanthene derivatives. Indeed, M. stipitatus DSM 14675 carrying an SA-type cluster produced totally different DKxanthene derivatives from those produced by M. xanthus DK1622 having an MX-type cluster under identical culture conditions. None of the DKxanthene derivatives produced by M. stipitatus DSM 14675 were identical to those produced by M. xanthus DK1622 in terms of molecular mass and HPLC retention time, suggesting that DKxanthenes produced by M. stipitatus DSM 14675 might be novel (Fig. 4, Table 3).

S. aurantiaca DW4/3-1 carrying an SA-type cluster was reported to produce five derivatives that were identical to five DKxanthenes produced by M. xanthus DK1622 having an MX-type cluster [6]. It was suggested that the PKS domains encoded by additional PKS genes dkxQR and dkxT in the SA-type cluster might be inactive in S. aurantiaca DW4/3-1 [6].

Thirteen DKxanthene derivatives were identified previously from M. xanthus DK1622 (MX type) [5, 6]. We found four new DKxanthene derivatives that were produced by M. xanthus DK1622 in addition to those previously reported (Table 3). CYS agar was used to cultivate M. xanthus in this study, whereas other growth media were used in the previous study [5, 6]. Thus, it appeared that M. xanthus produced different DKxanthene derivatives depending on the culture conditions.

Biological Function of DKxanthenes

We found that the DKxanthene fractions from M. stipitatus DSM 14675 and M. xanthus DK1622 inhibited the growth of fungi such as A. niger, C. albicans, and R. stolonifer. This is the first report on the antimicrobial activity of DKxanthenes. The growth inhibitory activity of the DKxanthene fractions from both M. stipitatus and M. xanthus against R. stolonifer was similar, but the activity of the DKxanthene fraction from M. xanthus DK1622 against A. niger and C. albicans was relatively weak compared with that of the fraction from M. stipitatus DSM 14675 (Fig. 6). DKxanthene derivatives from M. stipitatus were completely different to those from M. xanthus. Thus, it is possible that the antifungal activity of each derivative might be different.

M. xanthus DK1622 produced new DKxanthene derivatives (DKxanthene-516, -542, -574 isomer, and -588 isomer) in addition to the derivatives previously reported (DKxanthene-534, -556, -560, and -574) in this study (Table 3). It could be possible that the antifungal activity of DKxanthenes was not observed before this study because previously known derivatives showed no or very weak activity against fungi, whereas the newly produced derivatives showed strong inhibitory activity. Differences in assay conditions might be another possible reason why the antifungal activity of DKxanthenes had not been observed before this study. DKxanthenes from M. xanthus DK1622 did not show growth inhibitory activity against A. niger on potato dextrose agar plates, whereas those from M. stipitatus DSM 14675 showed obvious inhibitory activity under identical conditions (data not shown).

DKxanthenes are reported to be required for developmental sporulation in M. xanthus. Mutant cells of M. xanthus defective in DKxanthene synthesis produce severely reduced amounts of viable spores [5]. Unlike M. xanthus, the mutant cells of M. stipitatus defective in DKxanthene synthesis produced normal levels of heat-resistant viable spores compared with the wild-type cells. This suggested that DKxanthenes are not required for the formation of viable spores in M. stipitatus. It is possible that DKxanthenes have other roles in M. stipitatus, such as protecting cells from eukaryotic organisms rather than being a factor required for fruiting body formation, because it has antifungal activity.

Myxobacteria produce diverse antimicrobial substances [25, 26] that would confer advantages against other micro-organisms in the soil [27]. M. stipitatus DSM 14675 produces melithiazols, another group of antifungal substances, in addition to DKxanthenes [24]. The production of two antifungal substances, melithiazols and DKxanthenes, seems to be independent because the mutants defective in melithiazols produced DKxanthenes, and the mutants defective in DKxanthenes produced melithiazols (data not shown). Melithiazols inhibit electron transfer in the mitochondria [11]. The growth inhibitory mechanism of DKxanthenes against fungi is unknown at this moment. It will be interesting to elucidate the mechanism because DKxanthenes are a new group of antifungal substances.

Supplemental Materials

Conflict of Interest


The authors have no financial conflicts of interest to declare.

Fig 1.

Figure 1.Structure of DKxanthenes [5, 6].
Journal of Microbiology and Biotechnology 2018; 28: 1068-1077https://doi.org/10.4014/jmb.1802.02045

Fig 2.

Figure 2.Biosynthetic gene clusters of DKxanthene. DKxanthene biosynthetic gene clusters from Myxococcus stipitatus DSM 14675, Stigmatella aurantiaca DW4/3-1, and Myxococcus xanthus DK1622 are shown. Polyketide synthase (PKS); Non-ribosomal peptide synthetase (NRPS); PKS/NRPS hybrid. Arrows indicate the locations of the plasmid insertions, which disrupted the genes in the mutant strains.
Journal of Microbiology and Biotechnology 2018; 28: 1068-1077https://doi.org/10.4014/jmb.1802.02045

Fig 3.

Figure 3.High-performance liquid chromatography chromatograms of the culture extracts of M. stipitatus strains DSM 14675, KYC617, and KYC618.
Journal of Microbiology and Biotechnology 2018; 28: 1068-1077https://doi.org/10.4014/jmb.1802.02045

Fig 4.

Figure 4.High-resolution LC-MS analysis of the DKxanthenes produced by M. stipitatus DSM 14675 and M. xanthus DK1622. UV chromatograms of the DKxanthene fractions from M. stipitatus DSM 14675 (A) and M. xanthus DK1622 (B) at 410 nm. High-resolution mass spectra of the eight main peaks from M. stipitatus DSM 14675 (C) and M. xanthus DK1622 (D).
Journal of Microbiology and Biotechnology 2018; 28: 1068-1077https://doi.org/10.4014/jmb.1802.02045

Fig 5.

Figure 5.Effects of the inactivation of DKxanthene production on the formation of fruiting bodies. Approximately 1 × 106 cells of M. stipitatus DSM 14675 (A), KYC617 (B), and KYC618 (C) grown in CYE broth were placed on CYD plates as 20 μl spots and incubated at 30°C for 5 days. Cells aggregated and formed fruiting bodies consisting of a mass of slime and myxospores on the agar media. All three strains developed normal fruiting bodies. DSM 14675 formed yellow fruiting bodies, but KYC617 and KYC618 formed white fruiting bodies because they were defective in DKxanthene production. Bar, 0.2 mm.
Journal of Microbiology and Biotechnology 2018; 28: 1068-1077https://doi.org/10.4014/jmb.1802.02045

Fig 6.

Figure 6.Antifungal activity of DKxanthenes from M. stipitatus DSM 14675 and M. xanthus DK1622. Paper discs containing 100 μg of DKxanthene fractions from M. stipitatus DSM 14675 or M. xanthus DK1622 were placed on TSA plates that had been spread with Aspergillus niger ATCC 16404, Candida albicans ATCC 18804, or Rhizopus stolonifer KCCM 32398. The plates were then incubated at 30°C for 2 days.
Journal of Microbiology and Biotechnology 2018; 28: 1068-1077https://doi.org/10.4014/jmb.1802.02045

Table 1 . Microbial strains used in this study..

StrainsRelevant featuresSource or references
Myxococcus xanthus DK1622Wild type[28]
Myxococcus stipitatus DSM 14675Wild typeDSMZa
Myxococcus stipitatus KYC617DSM14675 MYSTI_06016::pHS221This study
Myxococcus stipitatus KYC618DSM14675 MYSTI_06014::pHS222This study
Myxococcus stipitatus KYC633DSM14675 MYSTI_06019::pHS243This study
Myxococcus stipitatus KYC634DSM14675 MYSTI_06018::pHS244This study
Myxococcus stipitatus KYC635DSM14675 MYSTI_06010::pHS245This study
Myxococcus stipitatus KYC636DSM14675 MYSTI_06005::pHS246This study
Myxococcus stipitatus KYC637DSM14675 MYSTI_06004::pHS247This study
Myxococcus stipitatus KYC638DSM14675 MYSTI_06002::pHS248This study
Pseudomonas aeruginosa ATCC 10145Gram negative bacteriumKCTCb
Staphylococcus aureus ATCC 25923Gram positive bacteriumKCTC
Aspergillus niger ATCC 16404Fungus (Ascomycota, mold)KCTC
Candida albicans ATCC 18804Fungus (Ascomycota, yeast)KCTC
Rhizopus stolonifer KCCM 32398Fungus (Zygomycota, mold)KCCMc

aDSMZ, Deutsche Sammlung von Mikroorganismen und Zellkukulturen GmbH..

bKCTC, Korean Collection for Type Cultures..

cKCCM, Korean Culture Center of Microorganisms..


Table 2 . Comparison of the DKxanthene biosynthetic genes from M. stipitatus DSM 14675 and S. aurantiaca DW4/3-1..

M. stipitatus DSM 14675S. aurantiaca DW4/3-1


ORF No.Product size (aa)Predicted functionPKS/NRPS motifIdentity/Similarity (%)GeneORF No.Product size (aa)
06019183hypothetical protein----
06018498NRPSA(N/A)77/87dkxA4842507
06017380acyl-CoA dehydrogenase85/91dkxB4841379
06016711PKSKS-ACP64/73dkxE4840739
060151,418PKSKS-KR-ACP59/70dkxF48391,461
060142,958NRPS/PKSC-A(thr)-PCP-KS-AT(mal)-DH-KR-ACP74/84dkxG48382,971
060131,834PKSKS-AT(mal)-DH-KR-ACP70/81dkxH48371,855
060121,833PKSKS-AT(mal)-DH-KR-ACP68/79dkxI48361,837
060111,436NRPSC-A(asn)-PCP-TE69/81dkxJ48351,433
06010366patatin-like phospholipase family protein68/81dkxK4834365
06009381arsenical pump-driving ATPase49/62dkxL4833388
06008165hypothetical protein45/62dkxP4832159
06007931PKSoMT-KR-ACP67/78dkxQR4831941
06006674radical SAM domain-containing protein83/89dkxS4830673
060051,835PKSKS-AT(mal)-DH-KR-ACP72/81dkxN48291,866
06004947PKSKS-AT(N/A)70/80dkxT4828949
0600387hypothetical protein75/87-482787
06002172alpha-L-arabinofuranosidase----

A, adenylation; aa, amino acid; ACP, acyl carrier protein; asn, asparagine; AT, acyltransferase; C, condensation; DH, dehydrase; KR, ketoreductase; KS, ketosynthase; mal, malonate; mmal, methyl malonate; N/A, not available; NRPS, non-ribosomal peptide synthetase; oMT, O-methyl transferase; ORF, open reading frame; PCP, peptidyl carrier protein; PKS, polyketide synthase; SAM, S-adenosylmethionine-dependent methyltransferase; TE, thioesterase..

Identity/Similarity: Identity and similarity to the corresponding proteins of S. aurantiaca DW4/3-1..


Table 3 . Comparison of the DKxanthenes produced by M. stipitatus DSM 14675 and M. xanthus DK1622..

RT(min)m/z ([M+H]+)Formula ([M+H]+)∆ppmDKxantheneKnown or novel
M. stipitatus DSM146756.16563.2880C31H39O6N41.935DKxanthene-562New
6.44547.2928C31H39O5N41.361DKxanthene-546New
6.53563.2875C31H39O6N40.888DKxanthene-562 isomerNew
6.88547.2923C31H39O5N40.539DKxanthene-546 isomerNew
7.12589.3031C33H41O6N40.883DKxanthene-588New
7.34529.2820C31H37O4N41.170DKxanthene-528New
7.44573.3083C33H41O5N41.142DKxanthene-572New
7.71529.2822C31H37O4N41.303DKxanthene-528 isomerNew
M. xanthus DK16224.46535.2556C29H35O6N40.524DKxanthene-534Known
4.94517.2455C29H33O5N40.744DKxanthene-516New
5.33561.2710C31H37O6N4-0.516DKxanthene-560Known
5.82575.2868C32H39O6N4-0.243DKxanthene-574Known
5.94543.2602C31H35O5N4-0.966DKxanthene-542New
6.32575.2875C32H39O6N41.269DKxanthene-574 isomerNew
6.53557.2758C32H37O5N4-1.050DKxanthene-556Known
6.81589.3028C33H41O6N40.136DKxanthene-588 isomerNew

The structural formula was estimated from the measured high-resolution mass spectrometry results using Xcalibur ver. 2.2 software (Thermo Scientific, USA). The molecular formula was selected within ±3 ppm mass accuracy..


References

  1. Reichenbach H. 2005. Myxococcales, pp. 1059-1144. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM (eds), Bergey's Manual of Systematic Bacteriology, 2nd Ed. Bergey's Manual Trust, East Lansing, MI, USA.
  2. Shimkets LJ, Dworkin M, Reichenbach H. 2006. The myxobacteria, pp. 31-115. In: Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (eds), The Prokaryotes, Vol. 7. Springer, New York, NY, USA.
    CrossRef
  3. Weissman KJ, Muller R. 2010. Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat. Prod. Rep. 27: 1276-1295.
    Pubmed CrossRef
  4. Herrmann J, Fayad AA, Müller R. 2017. Natural products from myxobacteria: novel metabolites and bioactivities. Nat. Prod. Rep. 34: 135-160.
    Pubmed CrossRef
  5. Meiser P, Bode HB, Muller R. 2006. The unique DKxanthene secondary metabolite family from the myxobacterium Myxococcus xanthus is required for developmental sporulation. Proc. Natl. Acad. Sci. USA 103: 19128-19133.
    Pubmed KoreaMed CrossRef
  6. Meiser P, Weissman KJ, Bode HB, Krug D, Dickschat JS, Sandmann A, et al. 2008. DKxanthene biosynthesis -understanding the basis for diversity-oriented synthesis in myxobacterial secondary metabolism. Chem. Biol. 15: 771-781.
    Pubmed CrossRef
  7. Burchard RP, Burchard AC, Parish JH. 1977. Pigmentation phenotype instability in Myxococcus xanthus. Can. J. Microbiol. 23: 1657-1662.
    Pubmed CrossRef
  8. Furusawa G, Dziewanowska K, Stone H, Settles M, Hartzell P. 2011. Global analysis of phase variation in Myxococcus xanthus. Mol. Microbiol. 81: 784-804.
    Pubmed KoreaMed CrossRef
  9. Laue BE, Gill RE. 1995. Using a phase-locked mutant of Myxococcus xanthus to study the role of phase variation in development. J. Bacteriol. 177: 4089-4096.
    Pubmed KoreaMed CrossRef
  10. Wenzel SC, Müller R. 2009. The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat. Prod. Rep. 26: 1385-1407.
    Pubmed CrossRef
  11. Sasse F, Steinmetz H, Höfle G, Reichenbach H. 1993. Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physico-chemical and biological properties. J. Antibiot. (Tokyo) 46: 741-748.
    Pubmed CrossRef
  12. Sasse F, Bohlendorf B, Herrmann M, Kunze B, Forche E, Steinmetz H, et al. 1999. Melithiazols, new betamethoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties. J. Antibiot. (Tokyo) 52: 721-729.
    Pubmed CrossRef
  13. Trowitzsch-Kienast W, Forche E, Wray V, Reichenbach H, Jurkiewicz E, Hunsmann G, Höfle G. 1992. Antibiotika aus gleitenden bakterien, 45.phenalamide, neue HIV-1-inhibitoren aus Myxococcus stipitatus Mx s40. Liebigs Ann. Chem. 1992: 659-779.
    CrossRef
  14. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, Fischbach MA, et al. 2011. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters. Nucleic Acids Res. 39: W339-W346.
    Pubmed KoreaMed CrossRef
  15. Weber T, Blin K, Duddela S, Krug D, Kim HU, Bruccoleri R, et al. 2015. antiSMASH 3.0 - a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 43: W237-W243.
    Pubmed KoreaMed CrossRef
  16. Johnson M, Zaretskaya I, Raytselis Y, Mereshuk Y, McGinnis S, Madden TL. 2008. NCBI BLAST: a better web interface. Nucleic Acids Res. 36: W5-W9.
    Pubmed KoreaMed CrossRef
  17. Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, et al. 2015. CDD: NCBI's conserved domain database. Nucleic Acids Res. 43: D222-D226.
    CrossRef
  18. Cho K, Zusman DR. 1999. Sporulation timing in Myxococcus xanthus is controlled by the espAB locus. Mol. Microbiol. 34: 714-725.
    Pubmed CrossRef
  19. Shi W, Köhler T, Zusman DR. 1994. Motility and chemotaxis in Myxococcus xanthus. Methods Mol. Genet. 3: 258-269.
  20. Shin H, Youn J, An D, Cho K. 2013. Production of antimicrobial substances by strains of myxobacteria Corallococcus and Myxococcus. Korean J. Microbiol. Biotechnol. 41: 44-51.
    CrossRef
  21. Zimbro MJ, Power DA, Miller SM, Wilson GE, Johnson JA (eds). 2009. Difco and BBL Manual: Manual of Microbiological Culture Media, 2nd Ed. Zimbro MJ, Power DA, Miller SM, Wilson GE, Johnson JA (eds). Becton Dickinson and Co., Sparks, MD, USA.
  22. Park S, Hyun H, Lee JS, Cho K. 2016. Identification of the phenalamide biosynthetic gene cluster in Myxococcus stipitatus DSM 14675. J. Microbiol. Biotechnol. 26: 1636-1642.
    Pubmed CrossRef
  23. Huntley S, Kneip S, Treuner-Lange A, Sogaard-Andersen L. 2013. Complete genome sequence of Myxococcus stipitatus strain DSM 14675, a fruiting myxobacterium. Genome Announc. 1: e0010013.
    Pubmed KoreaMed CrossRef
  24. Hyun H, Park S, Cho K. 2016. Analysis of the melithiazol biosynthetic gene cluster in Myxococcus stipitatus DSM 14675. Microbiol. Biotechnol. Lett. 44: 391-399.
    CrossRef
  25. Bérdy J. 2012. Thoughts and facts about antibiotics: where we a re now and where we are heading. J. Antibiot. (Tokyo) 65: 385-395.
    Pubmed CrossRef
  26. Schäberle TF, Lohr F, Schmitz A, König GM. 2014. Antibiotics from myxobacteria. Nat. Prod. Rep. 31: 953-972.
    Pubmed CrossRef
  27. Keane R, Berleman J. 2016. The predatory life cycle of Myxococcus xanthus. Microbiology 162: 1-11.
    Pubmed CrossRef
  28. Dey A, Vassallo CN, Conklin AC, Pathak DT, Troselj V, Wall D. 2016. Sibling rivalry in Myxococcus xanthus is mediated by kin recognition and a polyploid prophage. J. Bacteriol. 198: 994-1004.
    Pubmed KoreaMed CrossRef